Hugo Jimenez Selected Research

Transforming Growth Factor-beta Type I Receptor

7/2022	TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospects.
1/2014	TGFBR1 and cancer susceptibility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hugo Jimenez Research Topics

Disease

7	Neoplasms (Cancer) 07/2022 - 11/2013
2	Breast Neoplasms (Breast Cancer) 07/2022 - 06/2019
2	Brain Neoplasms (Brain Tumor) 06/2019 - 01/2018
1	Neoplasm Metastasis (Metastasis) 07/2022
1	Hepatocellular Carcinoma (Hepatoma) 06/2019
1	Disease Progression 06/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2014
1	Adenocarcinoma 01/2014
1	Colorectal Neoplasms (Colorectal Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

2	Transforming Growth Factor-beta Type I ReceptorIBA 07/2022 - 01/2014
2	Calcium Channels (Calcium Channel)IBA 06/2019 - 06/2019
1	Guanosine Triphosphate (GTP)IBA 07/2022
1	CytokinesIBA 01/2021
1	Toll-Like Receptor 4IBA 01/2021
1	InterferonsIBA 01/2021
1	InterleukinsIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	CateninsIBA 06/2019
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 06/2019
1	p38 Mitogen-Activated Protein KinasesIBA 06/2019
1	AntibodiesIBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2014
1	Antineoplastic Agents (Antineoplastics)IBA 06/2014

Therapy/Procedure

1	Radiotherapy 06/2019
1	Therapeutics 06/2019
1	Secondary Prevention 06/2014
1	Psychology Biofeedback (Biofeedback) 11/2013